National Eye Institute

The National Eye Institute (NEI) is one of the US National Institutes of Health that was established in 1968. The mission of NEI is to prolong and protect the vision of the American people. The NEI conducts and performs research into treating and preventing diseases affecting the eye or vision. The National Eye Institute is located in Bethesda, Maryland.


Some content from Wikipedia, licensed under CC BY-SA

Study provides clarity on supplements for protection against blinding eye disease

Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans, ...

Ophthalmology created May 06, 2013 | popularity 3 / 5 (2) | comments 0 | with audio podcast

Seven genetic risk factors found to be associated with age-related macular degeneration

An international group of researchers has discovered seven new regions of the human genome—called loci—that are associated with increased risk of age-related macular degeneration (AMD), a leading cause of blindness. The ...

Genetics created Mar 03, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

New NIH resources help growing number of Americans with vision loss

A 20-page large-print booklet and a series of videos to help people adapt to life with low vision are available from the National Eye Institute (NEI), a part of the National Institutes of Health. The materials were released ...

Ophthalmology created Feb 01, 2013 | popularity 5 / 5 (1) | comments 0

Scientists provide detailed view of brain protein structure: Results may help improve drugs for neurological disorders

Researchers have published the first highly detailed description of how neurotensin, a neuropeptide hormone which modulates nerve cell activity in the brain, interacts with its receptor. Their results suggest that neuropeptide ...

Medical research created Oct 10, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Avastin and Lucentis are equivalent in treating age-related macular degeneration

At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although ...

Ophthalmology created Apr 30, 2012 | popularity not rated yet | comments 1